How a rare drug made from scientists' blood saves babies from botulism

• An outbreak of infant botulism has affected at least 39 babies across the U.S., highlighting the critical importance of a rare medication derived from scientists' blood that effectively treats this serious condition.
• The rise in botulism cases underscores the urgent need for effective treatments, as the medication plays a vital role in saving lives, particularly among vulnerable infants who are at risk of severe complications from the disease.
• This situation is exacerbated by the recent increase in botulism cases linked to ByHeart baby formula, which has raised concerns about food safety and the availability of safe infant nutrition, emphasizing the need for stringent regulatory measures.

— via World Pulse Now AI Editorial System